Hantech Bio-Technology Co., Ltd. (TPEX:1294)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Personal Products	778.54M	748.42M	625.14M	302.52M	240.29M
Personal Products Growth	4.02%	19.72%	106.65%	25.89%	-9.90%
Total	778.54M	748.42M	625.14M	302.52M	240.29M
Total Growth	4.02%	19.72%	106.65%	25.89%	-9.90%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Taiwan	770.01M	735.07M	620.03M	293.31M	231.24M
Taiwan Growth	4.75%	18.55%	111.39%	26.84%	-10.41%
China	5.09M	10.25M	2.55M	-	-
China Growth	-50.29%	301.96%	-	-	-
Singapore	1.54M	631.00K	1.06M	-	-
Singapore Growth	144.22%	-40.19%	-	-	-
Other	1.90M	2.48M	1.51M	9.21M	9.06M
Other Growth	-23.20%	64.11%	-83.61%	1.70%	39286.96%
Total	778.54M	748.42M	625.14M	302.52M	240.29M
Total Growth	4.02%	19.72%	106.65%	25.89%	-9.90%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error